Yes, there is a suggestion of efficacy with Provenge, but given that the MOA does not stand up under close scrutiny, and given the small numbers of patients enrolled in the trials, any respectable scientist would be cautious about saying the treatment works.
jellybean, the panel voted 13-4. I believe the panel knew whether they were voting for approval or approvable.
Much of the conversation since March 29th has centered on Drs. Hussain and Scher, two of the no votes. The 13 yes votes came from professionals most would consider respectable.
Best,
Geoff
